These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36074703)

  • 1. Ultrasound-assisted carbon nanoparticle suspension mapping versus dual tracer-guided sentinel lymph node biopsy in patients with early breast cancer (ultraCars): phase III randomized clinical trial.
    Zhang L; Cheng M; Lin Y; Zhang J; Shen B; Chen Y; Yang C; Yang M; Zhu T; Gao H; Ji F; Li J; Wang K
    Br J Surg; 2022 Nov; 109(12):1232-1238. PubMed ID: 36074703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer.
    Hua B; Li Y; Yang X; Ren X; Lu X
    World J Surg Oncol; 2022 Aug; 20(1):253. PubMed ID: 35941602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial.
    Jung SY; Han JH; Park SJ; Lee EG; Kwak J; Kim SH; Lee MH; Lee ES; Kang HS; Lee KS; Park IH; Sim SH; Jeong HJ; Kwon Y; Lee DE; Kim SK; Lee S
    Ann Surg Oncol; 2019 Aug; 26(8):2409-2416. PubMed ID: 31065958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial.
    Nguyen CL; Zhou M; Easwaralingam N; Seah JL; Azimi F; Mak C; Pulitano C; Warrier S
    Ann Surg Oncol; 2023 Oct; 30(11):6520-6527. PubMed ID: 37402976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial.
    Bargon CA; Huibers A; Young-Afat DA; Jansen BAM; Borel-Rinkes IHM; Lavalaye J; van Slooten HJ; Verkooijen HM; van Swol CFP; Doeksen A
    Ann Surg; 2022 Nov; 276(5):913-920. PubMed ID: 35894448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing single or dual tracing modality on sentinel lymph node biopsy from patients who plan to omitting axillary lymph node dissection referring to the criteria of Z0011 trial: a retrospective study.
    Xu Y; Wu H; Zhang W; Shen Y; Jiang Y; Meng L
    Updates Surg; 2022 Jun; 74(3):1073-1078. PubMed ID: 35389176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a carbon nanoparticle suspension for sentinel lymph node mapping in patients with early breast cancer: a retrospective cohort study.
    Zhang L; Huang Y; Yang C; Zhu T; Lin Y; Gao H; Yang M; Cheng M; Wang K
    World J Surg Oncol; 2018 Jun; 16(1):112. PubMed ID: 29914538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomised Controlled Trial.
    Man V; Suen D; Kwong A
    Ann Surg Oncol; 2023 Jun; 30(6):3237-3244. PubMed ID: 36849573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Cohort Study on the Long-term Oncologic Outcomes of Sentinel Lymph Node Mapping Methods (Dye-Only versus Dye and Radioisotope Mapping) in Early Breast Cancer: A Propensity Score-Matched Analysis.
    Lim C; Kang E; Jung JG; Cheun JH; Kim HK; Lee HB; Moon HG; Han W
    Cancer Res Treat; 2023 Apr; 55(2):562-569. PubMed ID: 36164944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial (SMART study).
    Vidya R; Khosla M; Laws S; Harvey J; Kaushik M; Mullapudi NA; Macmillan D
    Surgeon; 2023 Apr; 21(2):128-134. PubMed ID: 35551871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial.
    Kuemmel S; Holtschmidt J; Gerber B; Von der Assen A; Heil J; Thill M; Krug D; Schem C; Denkert C; Lubitz J; Blohmer JU; Reinisch M; Hötzeldt M; Seither F; Nekljudova V; Schwidde I; Uhrhan K; Von Minckwitz G; Rezai M; Mulowski J; Loibl S; Kuehn T
    J Clin Oncol; 2019 Jun; 37(17):1490-1498. PubMed ID: 31042410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-port endoscopic-sentinel lymph node biopsy combined with indocyanine green and carbon nanoparticles in breast cancer.
    Wang ZH; Gang TR; Wu SS; Lu C; Gao GX; Xu W; Ding GQ; Qu X; Zhang ZT
    Surg Endosc; 2023 Oct; 37(10):7591-7599. PubMed ID: 37460818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy.
    Tasdoven I; Balbaloglu H; Erdemir RU; Bahadir B; Guldeniz Karadeniz C
    Medicine (Baltimore); 2022 Dec; 101(52):e32545. PubMed ID: 36596061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM
    Staubach P; Scharl A; Ignatov A; Ortmann O; Inwald EC; Hildebrandt T; Gerken M; Klinkhammer-Schalke M; Scharl S; Papathemelis T
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1813-1823. PubMed ID: 33230583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing carbon nanoparticles and indocyanine green for sentinel lymph node mapping in endometrial cancer: A randomized-controlled single-center trial.
    He M; Liang S; Deng H; Zhang G; Wang Z; Yang X; Wang Y; Li Y; Sun X; Wang J
    J Surg Oncol; 2023 Aug; 128(2):332-343. PubMed ID: 37027324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
    Lee EG; Lee DE; Jung SY; Han JH; Kim SK; Chae H; Sim SH; Lee KS; Lee S
    Ann Surg Oncol; 2024 Aug; 31(8):5141-5147. PubMed ID: 38717546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study.
    Somashekhar SP; Kumar CR; Ashwin KR; Zaveri SS; Jampani A; Ramya Y; Parameswaran R; Rakshit S
    Clin Breast Cancer; 2020 Oct; 20(5):e576-e583. PubMed ID: 32389561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.